Femoston in the substitute hormonotherapy of early and late climacteric disorders in patients with postovariectonomical syndrome, which were subjected to surgical intervations in their transitional age

S. V. Beskrovny; Бескровный С. В.; Y. V. Tsveliov; Цвелев Ю. В.; V. F. Bezhenar; Беженарь В. Ф.; J. M. Karpishchenko; Карпищенко Ж. М.

doi:10.17816/JOWD91106

Femoston in the substitute hormonotherapy of early and late climacteric disorders in patients with postovariectonomical syndrome, which were subjected to surgical intervations in their transitional age

Authors: Beskrovny S.V.¹, Tsveliov Y.V.¹, Bezhenar V.F.¹, Karpishchenko J.M.¹
Affiliations:
1. Russian Military Medical Academy
Issue: Vol 51, No 3 (2002)
Pages: 90-93
Section: Scientific activity
URL: https://journals.rcsi.science/jowd/article/view/91106
DOI: https://doi.org/10.17816/JOWD91106
ID: 91106

Cite item

Full Text

Abstract
Full Text
About the authors
References
Supplementary files
Statistics

Abstract

The results of clinical femoston use, which is the choose preparation in the late climacteric disorder therapy are presented in this article. This preparation occupies according to extent of gestagen charge the intermediate site between cycle-progine (divine) and climin. The increased gestagenic component of femoston provides this preparation advantage in therapy of early POES symptoms, especially in patients being subjected to the intervention in connection with hyperplasic processes in genitalia.